37497-84-0 Usage
General Description
Methyl 1-oxo-1,2-dihydro-4-isoquinolinecarboxylate is a chemical compound with the molecular formula C12H11NO3. It is a ester derivative of isoquinolinecarboxylic acid and is commonly used as a building block in the synthesis of various pharmaceutical compounds. It has been studied for its potential pharmacological properties, including its ability to act as a cholinesterase inhibitor and its potential use in the treatment of neurodegenerative diseases such as Alzheimer's. Additionally, it has been investigated for its potential role in the synthesis of novel bioactive molecules. Overall, methyl 1-oxo-1,2-dihydro-4-isoquinolinecarboxylate has shown promise in various research studies and holds potential for further exploration in pharmaceutical and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 37497-84-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,4,9 and 7 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 37497-84:
(7*3)+(6*7)+(5*4)+(4*9)+(3*7)+(2*8)+(1*4)=160
160 % 10 = 0
So 37497-84-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H9NO3/c1-15-11(14)9-6-12-10(13)8-5-3-2-4-7(8)9/h2-6H,1H3,(H,12,13)
37497-84-0Relevant articles and documents
A new method using 1,3,5-triazine as an umpolung hydrogen cyanide equivalent toward the syntheses of isoquinolinone and 2-pyridone derivatives
Hayashida, Joji,Yoshida, Shinya
, p. 3876 - 3879 (2018)
An investigation of Hermecz and Hartenstein's cyclization methods was conducted. Overcoming the limited substrate scope allowed the expansion of the synthetic application of 1,3,5-triazine as an umpolung hydrogen cyanide equivalent. The reaction proceeded under mild conditions to provide various isoquinolinone and 2-pyridone derivatives with excellent yields.
Bicyclic and tricyclic heteroaromatic compounds
-
, (2008/06/13)
Disclosed are compounds of the formula: and the pharmaceutically acceptable salts thereof, wherein W, Q, X, X1, Y and Z are as defined herein. These compounds bind with high selectivity and/or high affinity to the benzodiazepine site of GABAsu